In Silico Analysis of Non-synonymous Mutations in the durA Gene and Their Effects on the Stability and Physicochemical Properties of Duramycin
Abstract
Duramycin is a lantibiotic peptide encoded by the durA gene, known for its antimicrobial activity against Gram-positive bacteria. This study aimed to evaluate the effects of single-point mutations on the stability and structural integrity of duramycin using a comprehensive in silico approach. Five variants—C1S, F7A, T11Y, D15E, and K19V—were designed and assessed using I-Mutant2.0 to predict their impact on protein stability. ProtParam analysis was conducted to determine molecular weight, isoelectric point (pI), net charge at pH 7, instability index, aliphatic index, and hydropathicity (GRAVY). In addition, PEP-FOLD3 was employed to model the 3D conformations of each mutant peptide. Results showed that K19V improved peptide stability and increased aliphatic index and GRAVY score, indicating enhanced hydrophobicity and potential thermal stability. In contrast, F7A led to a major structural shift marked by an α-helical conformation and reduced stability. C1S and T11Y induced minor destabilizing effects, while D15E offered a moderately stabilizing substitution with minimal structural deviation. Overall, this study highlights the functional relevance of C-terminal and hydrophobic residues in maintaining duramycin’s structural compactness and provides a framework for future design of optimized antimicrobial peptides through rational mutation
References
Capecchi, A., Cai, X., & Rees, D. C. (2021). Predicting protein stability changes upon single-point mutations using bioinformatics tools. Frontiers in Bioengineering and Biotechnology, 9, 652408. https://doi.org/10.3389/fbioe.2021.652408.
Capriotti, E., Fariselli, P., & Casadio, R. (2005). I-Mutant2.0: Predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Research, 33(Web Server issue), W306–W310. https://doi.org/10.1093/nar/gki375
Chatterjee, C., Paul, M., Xie, L., & van der Donk, W. A. (2005). Biosynthesis and mode of action of lantibiotics. Chemical Reviews, 105(2), 633–684. https://doi.org/10.1021/cr030105v.
Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M. R., Appel, R. D., & Bairoch, A. (2005). Protein identification and analysis tools on the ExPASy server. In J. M. Walker (Ed.), The proteomics protocols handbook (pp. 571–607). Humana Press.
Ge, Y., Cai, Y., Liu, J., & Zhang, L. (2019). Engineering of lantibiotic peptides: A review of strategies and applications. Biotechnology Advances, 37(6), 107446. https://doi.org/10.1016/j.biotechadv.2019.107446.
Ikai, A. (1980). Thermostability and aliphatic index of globular proteins. Journal of Biochemistry, 88(6), 1895–1898. https://doi.org/10.1093/oxfordjournals.jbchem.a133168.
Huo, L., Öster, C., Knerr, P. J., & van der Donk, W. A. (2012). Biosynthesis and structures of the lantibiotic duramycin. Journal of the American Chemical Society, 134(50), 21010–21013. https://doi.org/10.1021/ja309744r.
Jumper, J., Evans, R., Pritzel, A., et al. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583–589. https://doi.org/10.1038/s41586-021-03819-2
Khondoker, M. A. H., Islam, M. T., & Sultana, M. (2023). In silico evaluation of physicochemical and structural properties of novel peptides for therapeutic design. Computational Biology and Chemistry, 103, 107805. https://doi.org/10.1016/j.compbiolchem.2022.107805
Lamiable, A., Thévenet, P., Rey, J., Vavrusa, M., Derreumaux, P., & Tufféry, P. (2016). PEP-FOLD3: Faster de novo structure prediction for linear peptides in solution and in complex. Nucleic Acids Research, 44(W1), W449–W454. https://doi.org/10.1093/nar/gkw329.
Li, B., Sher, D., Kelly, L., Shi, Y., Huang, K., Knerr, P. J., ... & van der Donk, W. A. (2010). Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteria. Proceedings of the National Academy of Sciences, 107(25), 10430–10435. https://doi.org/10.1073/pnas.1004081107.
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016). Antimicrobial peptides: An emerging category of therapeutic agents. Frontiers in Cellular and Infection Microbiology, 6, 194. https://doi.org/10.3389/fcimb.2016.00194
Ortega, M. A., Hao, Y., Walker, M. C., et al. (2015). Structure and mechanism of the tRNA-dependent lantibiotic dehydratase NisB. Nature, 517(7535), 509–512. https://doi.org/10.1038/nature13889
Torres, M. D. T., Sothiselvam, S., Lu, T. K., & de la Fuente-Nunez, C. (2019). Peptide design principles for antimicrobial applications. Journal of Molecular Biology, 431(18), 3547–3567. https://doi.org/10.1016/j.jmb.2019.06.031.
Van Heel, A. J., Montalbán-López, M., Kuipers, O. P. (2016). Evaluating and engineering the thermostability of lantibiotic peptides. Methods in Molecular Biology, 1401, 359–373. https://doi.org/10.1007/978-1-4939-3375-4_24.
Veltri, D., Kamath, U., & Shehu, A. (2018). Deep learning improves antimicrobial peptide recognition. Bioinformatics, 34(16), 2740–2747. https://doi.org/10.1093/bioinformatics/bty179.
Wang, G., Li, X., & Wang, Z. (2022). APD3: The antimicrobial peptide database as a tool for research and education. Nucleic Acids Research, 50(D1), D488–D494. https://doi.org/10.1093/nar/gkab1052.
Waghu, F. H., Barai, R. S., Gurung, P., et al. (2016). CAMP: Collection of sequences and structures of antimicrobial peptides. Nucleic Acids Research, 44(D1), D1094–D1097. https://doi.org/10.1093/nar/gkv1051
You, Y. O., & van der Donk, W. A. (2007). Mechanistic investigations of the dehydration reaction in the biosynthesis of lacticin 481. Journal of Biological Chemistry, 282(9), 6313–6320. https://doi.org/10.1074/jbc.M609425200.
Zhou, L., van Heel, A. J., & Kuipers, O. P. (2020). Rational design and engineering of lantibiotic peptides for enhanced stability and antimicrobial activity. Computational and Structural Biotechnology Journal, 18, 1180–1191. https://doi.org/10.1016/j.csbj.2020.05.004
Copyright (c) 2025 Yulianto Ade Prasetya, Tjie Kok, Mariana Wahjudi

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


